| Genoma Home Health Care Agency Inc | |
| 4621 Lake Worth Rd, Greenacres, Florida 33463 | |
| (561) 410-5622 | |
| Not Available |
| Name | Genoma Home Health Care Agency Inc |
|---|---|
| Location | 4621 Lake Worth Rd, Greenacres, Florida |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 683179 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 33401, 33405, 33411, 33415, 33417, 33463 |
| NPI Number | 1972928455 |
| Organization Name | GENOMA HOME HEALTH CARE AGENCY, INC. |
| Address | 1499 Forest Hill Blvd, Suite 106, Lake Clarke Shores, FL 33406 |
| Phone Number | 561-410-5622 |
News Archive
CEL-SCI Corporation announced today it has received approval from the first Taiwanese Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Delcath Systems, Inc., announced today that the first patients in Germany have been treated with the Delcath Hepatic CHEMOSAT Delivery System at the Johann Wolfgang Goethe University Hospital, a premier European cancer treatment and research center located in Frankfurt. The cases were treated as part of the initial launch and training agreement the Company announced with the hospital in December 2011.
Researchers at the La Jolla Institute for Allergy & Immunology have shown that cytomegalovirus (CMV) in the salivary glands can be reduced , and in some cases eliminated , through the use of antibodies to enhance the disease-fighting power of the immune system.
Almost 10 per cent of bowel cancer patients die within a month of being diagnosed according to new analysis by the National Cancer Intelligence Network (NCIN), published today.
Mucus coats our airways' internal surfaces. The viscous gel humidifies the lungs and prevents viruses and other small particles like diesel soot from entering the body unchecked. Previously unclear was the extent to which such nanoparticles are able to move through the lungs' mucus. Here, the research evidence was contradictory. Scientists could not explain why, in inhaled medication development, drug nanoparticles often simply got stuck in the mucus never making it to their target destination inside the lung cells.
› Verified 9 days ago
| Quality Rating: | Not Available* |
| * The number of patient episodes for this measure is too small to report. | |
News Archive
CEL-SCI Corporation announced today it has received approval from the first Taiwanese Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Delcath Systems, Inc., announced today that the first patients in Germany have been treated with the Delcath Hepatic CHEMOSAT Delivery System at the Johann Wolfgang Goethe University Hospital, a premier European cancer treatment and research center located in Frankfurt. The cases were treated as part of the initial launch and training agreement the Company announced with the hospital in December 2011.
Researchers at the La Jolla Institute for Allergy & Immunology have shown that cytomegalovirus (CMV) in the salivary glands can be reduced , and in some cases eliminated , through the use of antibodies to enhance the disease-fighting power of the immune system.
Almost 10 per cent of bowel cancer patients die within a month of being diagnosed according to new analysis by the National Cancer Intelligence Network (NCIN), published today.
Mucus coats our airways' internal surfaces. The viscous gel humidifies the lungs and prevents viruses and other small particles like diesel soot from entering the body unchecked. Previously unclear was the extent to which such nanoparticles are able to move through the lungs' mucus. Here, the research evidence was contradictory. Scientists could not explain why, in inhaled medication development, drug nanoparticles often simply got stuck in the mucus never making it to their target destination inside the lung cells.
› Verified 9 days ago
News Archive
CEL-SCI Corporation announced today it has received approval from the first Taiwanese Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Delcath Systems, Inc., announced today that the first patients in Germany have been treated with the Delcath Hepatic CHEMOSAT Delivery System at the Johann Wolfgang Goethe University Hospital, a premier European cancer treatment and research center located in Frankfurt. The cases were treated as part of the initial launch and training agreement the Company announced with the hospital in December 2011.
Researchers at the La Jolla Institute for Allergy & Immunology have shown that cytomegalovirus (CMV) in the salivary glands can be reduced , and in some cases eliminated , through the use of antibodies to enhance the disease-fighting power of the immune system.
Almost 10 per cent of bowel cancer patients die within a month of being diagnosed according to new analysis by the National Cancer Intelligence Network (NCIN), published today.
Mucus coats our airways' internal surfaces. The viscous gel humidifies the lungs and prevents viruses and other small particles like diesel soot from entering the body unchecked. Previously unclear was the extent to which such nanoparticles are able to move through the lungs' mucus. Here, the research evidence was contradictory. Scientists could not explain why, in inhaled medication development, drug nanoparticles often simply got stuck in the mucus never making it to their target destination inside the lung cells.
› Verified 9 days ago
Striving For Excellence Home Health Care Inc Location: 5199 10th Ave N Ste 110, Greenacres, Florida 33463 Ratings: Phone: (561) 968-7025 | |
Twentyfour Seven Home Health Care Inc Location: 6801 Lake Worth Rd Ste 126, Greenacres, Florida 33467 Ratings: NA Phone: (561) 963-6400 | |
Nursing Care Services, Inc Location: 7328 Lakeworth Rd, Greenacres, Florida 33467 Ratings: Phone: (561) 433-1991 | |
Absolute Caregivers Home Health Agency Inc Location: 4000 S 57th Ave Ste 203, Greenacres, Florida 33463 Ratings: Phone: (561) 844-7196 | |
All Health Care Services Inc Location: 6801 Lake Worth Rd Ste 219, Greenacres, Florida 33467 Ratings: Phone: (561) 487-0553 | |
Genoma Home Health Care Agency Inc Location: 4621 Lake Worth Rd, Greenacres, Florida 33463 Ratings: NA Phone: (561) 410-5622 |